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Active Transcriptional Repression by the Rb±E2F
Complex Mediates G1 Arrest Triggered
by p16INK4a, TGFb, and Contact Inhibition
can act as both an oncogene and a tumor suppressor
(Weinberg, 1996). However, these complex biological
effects of E2F say little about how these proteins work
to regulate the cell cycle.
The activity of Rb is regulated by G1 cyclin-dependent
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kinases (CDKs), which phosphorylate Rb during G1 (Mi-St. Louis, Missouri 63110
hara et al., 1989; Ludlow et al., 1990; Hinds et al., 1992;
Roberts et al., 1994; Sherr and Roberts, 1995; Sherr,
1996; Lundberg and Weinberg, 1997). Initially, CDK4 andSummary
6 interact with D family cyclins to form active kinases
that phosphorylate Rb during mid G1. Subsequently,Rb inhibits progression from G1 to S phase of the cell
cyclin E is expressed, and it forms an active kinase withcycle. It associates with a number of cellular proteins;
CDK2 that phosphorylates Rb near the end of G1. Thishowever, the nature of these interactions and their
hyperphosphorylation of Rb disrupts its association torelative significance in cell cycle regulation are still
E2F and allows transcription of S phase genes andunclear. We present evidence that Rb must normally
movement of cells from G1 into S phase. CDK4/6 activityinteract with the E2F family of transcription factors to
is regulated by the INK family of inhibitors (p16INK4a,arrest cells in G1, and that this arrest results from
p15INK4b, p18INK4c, and p19INK4d), which block their activityactive transcriptional repression by the Rb±E2F com-
(Sherr and Roberts, 1995). Like Rb, p16INK4a has beenplex, not from inactivation of E2F. Thus, a major role
shown to be a tumor suppressor and is mutated in aof E2F in cell cycle regulation is assembly of this re-
high percentage of tumor cells (Palmero and Peters,pressor complex. We demonstrate that active repres-
1996).sion by Rb±E2F mediates the G1 arrest triggered by
One regulator of the G1 to S phase transition in epithe-TGFb, p16INK4a, and contact inhibition.
lial cells is transforming growth factor b (TGFb) (Mas-
sague, 1996). TGFb appears to regulate cell cycle pro-
gression at several different levels. It can decrease theIntroduction
activity of the G1/S phosphatase cdc25A (Iavarone and
Massague, 1997), which may be required for activationThe retinoblastoma protein (Rb) is an important regula-
of CDK4/6, and it can decrease expression of CDK4tor of the G1 to S phase transition (Ewen, 1994; Wein-
(Ewen et al., 1993, 1995). Additionally, TGFb induces theberg, 1995). Rb has been shown to interact with a num-
accumulation of the CDK inhibitors p15INK4b and p27Kip1ber of cellular proteins; however, it is still unclear which
(Reynisdottir et al., 1995). While p15INK4b selectivelyof these interactions are important for Rb function in
blocks the activity of CDK4/6, p27Kip1 can inhibit the
vivo. The best studied of these Rb-binding proteins is
activity of CDK2, which is also required for transition of
the E2F family of transcription factors (Chellappan et
cells from G1 to S phase and for progression through
al., 1991; Nevins, 1992; La Thangue, 1994; Lam and La S phase (Roberts et al., 1994; Sherr, 1996).
Thangue, 1994; Adams and Kaelin, 1996; Slansky and Proliferation of epithelial cells is also regulated by
Farnham, 1996). Interaction with Rb not only blocks tran- cell±cell contact. One consequence of cell±cell contact
scriptional activation by E2F; the Rb±E2F complex that is an increase in the CDK inhibitor p27Kip1 and a decrease
forms at the promoter actively represses transcription in the level of cyclin D1 (Polyak et al., 1994; St. Croix et
of cell cycle genes (Hamel et al., 1992; Weintraub et al., al., 1998). As with overexpression of p16INK4a and TGFb
1992, 1995; Adnane et al., 1995; Bremner et al., 1995; treatment, the result is accumulation of hypophosphory-
Sellers et al., 1995; Luo et al., 1998). However, it has not lated Rb and G1 arrest. This phenomenon is known as
been determined whether the most important role of contact inhibition, and mutations that overcome contact
Rb is blocking transcriptional activation by E2F, or the inhibition are common in tumor cells.
formation of the active Rb±E2F repressor complex. Here, we provide evidence that Rb must normally in-
The gene for E2F-1 has been knocked out in mice, teract with E2F to arrest cells in G1. We also show that
and the mice develop relatively normally and are fertile it is repression by the Rb±E2F complex, not an Rb-
(Field et al., 1996; Yamasaki et al., 1996). However, they mediated block in transcriptional activation by E2F, that
later exhibit testicular atrophy and exocrine gland dys- is responsible for this arrest. We show that active repres-
plasia, and they develop a variety of tumors. These re- sion by Rb±E2F mediates the G1 arrest caused by TGFb,
sults suggest that E2F-1 may be necessary to maintain p16INK4a, and contact inhibition.
some tissues, but it can also act as a tumor suppressor
in several other tissues. However, even though E2F-1 Results
is not required for proliferation of most normal cells,
tumor cell proliferation is inhibited in E2F-1(2/2) mice An E2F Mutant Containing Only the DNA-Binding
(Pan et al., 1998; Tsai et al., 1998). Therefore, E2F-1 Domain Blocks E2F Site Activity
E2F family members share a similar DNA-binding do-
main and bind a similar DNA sequence. Thus, it ap-* To whom correspondence should be addressed (e-mail: ddean@
im.wustl.edu). peared that overexpression of an E2F DNA-binding
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Figure 1. E2F-DB Displaces Wild-Type E2F
and Rb±E2F Complexes from E2F Sites and
Blocks E2F Site Function
(A) E2F-DB blocks E2F activity in transfection
assays. The indicated E2F family or DP-1 ex-
pression vectors (0.5 mg) were cotransfected
into 60 mm plates of U2OS cells along with 2.0
mg of the minimal E2F site reporter construct
E2F-CAT (Weintraub et al., 1992). Similar re-
sults were also obtained with the Rb(2) C33A
cell line (results not shown). Where indicated,
cells were also cotransfected with 1 mg of the
E2F-DB expression vector. One microgram
of empty vector was cotransfected in plates
that did not receive the E2F-DB expression
vector. Results are representative of at least
three separate assays, each in duplicate.
(B) Stable expression of E2F-DB and E2F-
DB(E132) in cells. Colonies from stable trans-
fection of Mv1Lu cells, C2C12 myoblasts, and
U2OS cells with E2F-DB were analyzed for
expression of E2F-DB. Western blots from
pooled clones are shown for the different cell
lines. A low level of E2F-1 is evident in each
of the cell lines upon a long exposure. The
left-hand lane shows the position of migration
of full-length E2F-1 from cells transiently
transfected with an E2F-1 expression vector.
A number of individual clones expressing E2F-DB were obtained, two such clones for Mv1Lu cells are shown (clones from U2OS cells are
shown in Figure 2C).
(C) E2F-DB displaces free E2F and complexes between E2F and Rb family members from E2F sites. Gel retardation assay using extracts
from untransfected (UT) Mv1Lu cells and cells stably expressing E2F-DB (3B2 clone in [C]). The triangles indicate decreasing concentration
of probe in the assays. Note the absence of binding of free E2F and complexes between E2F and Rb family members in the cells expressing
E2F-DB as the probe becomes limiting.
(D) E2F-DB blocks the silencer activity of E2F sites. A reporter construct containing E2F sites and an ATF enhancer (pE2F-ATF-CAT) or a
reporter construct where the E2F sites are mutated (pE2Fm-ATF-CAT) (Weintraub et al., 1992) was transfected into wild-type Mv1Lu cells or
cells expressing E2F-DB. Note that the E2F sites are silencers in wild-type Mv1Lu cells, but not in cells expressing E2F-DB. As a control,
cells were cotransfected with an expression vector for adenovirus protein E1a (Weintraub et al., 1992), which binds Rb and blocks its interaction
with E2F.
domain (E2F-DB) would displace wild-type E2F and Rb± E2F from the promoter of cell cycle genes. If the trans-
activation domain of E2F is required for progression ofE2F complexes from E2F-binding sites. In fact, it has
been demonstrated previously that the E2F-DB will cells from G1 to S phase, then expression of E2F-DB
should arrest cells in G1. Alternatively, if the major roleblock transactivation by wild-type E2F (Fan and Bertino,
1997). We used a mutant form of E2F-1 (amino acids of E2F in the cell cycle is to form an active repressor
complex with Rb at the promoter, then displacement of1±374) containing the DNA-binding domain but lacking
the transactivation domain and Rb-binding site to deter- wild-type E2F (by E2F-DB) would not block the G1/S
transition. In colony formation assays performed withmine the consequence of displacing wild-type E2F and
Rb±E2F complexes from promoters. various Rb(1)/p53(1) cell lines, we did not observe
growth suppression when an expression vector for E2F-To demonstrate that E2F-DB indeed blocks E2F func-
tion, we cotransfected an expression vector for E2F-DB DB was transfected (results not shown). Western blots
of pooled colonies from these assays showed a highalong with a reporter containing E2F sites in the context
of a minimal promoter. E2F-DB blocked the enhancer level of expression of E2F-DB (Figure 1B). When individ-
ual clones were examined for expression of the E2F-activity of E2F sites in the minimal promoter setting,
even when expression vectors for different E2F family DB, we found levels much greater than that of endoge-
nous E2F-1 (Figure 1B, Figure 2C, and results notmembers were cotransfected into Rb(2) C33A cells or
Rb(1) U2OS cells (Figure 1A and results not shown). shown). However, even though these clones stably over-
express E2F-DB, we had not yet demonstrated that E2F-E2F-DB(E132), which contains a mutation that blocks
DNA binding (but does not prevent interaction with DP DB actually displaces wild-type E2F from E2F sites in
these cells.proteins or CDK2/cyclin A) (Cress et al., 1993), had no
effect on E2F site activity in these transfection assays
(results not shown). Thus, DNA binding of E2F-DB is E2F-DB Displaces Wild-Type E2F in Stable
required for its function. Cell Lines
To determine whether E2F-DB was actually displacing
wild-type E2F from promoter sites in the stable transfec-Stable Expression of E2F-DB in Cells
Based on the above results, expression of E2F-DB tants, gel retardation assays were done. We found a
predominant complex with E2F-DB in the cell extracts,would be expected to displace endogenous wild-type
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these gel shift assays) these high levels of E2F-DB are
likely to be displacing wild-type E2F and Rb±E2F com-
plexes from E2F sites in the stable cell lines.
E2F-DB Blocks Recruitment of the Rb±E2F
Repressor Complex to Promoters
We and others have found that Rb can function as an
active transcriptional repressor while tethered to a pro-
moter through binding to E2F (Hamel et al., 1992; Wein-
traub et al., 1992, 1995; Adnane et al., 1995; Bremner
et al., 1995; Sellers et al., 1995). There appears to be
two mechanisms for this repression. First, Rb can inter-
act with the transactivation domains of surrounding
transcription factors on the promoter (through a site
distinct from the E2F-binding site) and block their inter-
action with the basal transcription complex (Weintraub
et al., 1992, 1995). Second, while bound to E2F, Rb can
recruit histone deacetylase, which induces nucleosome
assembly, thereby blocking access of transcription fac-
tors to the promoter (Brehm et al., 1998; Luo et al., 1998;
Magnaghi-Jaulin et al., 1998). The result is that E2F sites
can function as transcriptional silencers when the Rb±
E2F complex forms at these sites (Figure 1D and Wein-
traub et al., 1992).
Figure 2. E2F-DB Prevents Growth Arrest by p16INK4a We wondered whether stable expression of E2F-DB
(A) E2F-DB blocks growth suppression by p16INK4a. p16INK4a(2) U2OS would block interaction of Rb±E2F with E2F sites,
cells on 10 cm plates were cotransfected with PuroBabe vector and thereby preventing them from acting as transcriptional
expression vectors for p16INK4a and GFP. Transfected cells were silencers. A reporter containing E2F sites and an adja-
selected with puromycin for 2 weeks, and the percentage of GFP(1)
cent enhancer was transfected into wild-type cells andcolonies was determined.
cells stably expressing E2F-DB. In wild-type cells, E2F(B) p16INK4a±GFP and wild-type p16INK4a cause a similar accumulation
of hypophosphorylated Rb in U2OS cells. Cells transfected with the sites acted as silencers, inhibiting the activity of sur-
indicated expression vectors were sorted for GFP expression and rounding enhancers on the promoter (Figure 1D). This
analyzed by Western blot for phosphorylation of Rb. ªppRbº indi- activity was blocked when the adenovirus E1a protein,
cates hyperphosphorylated Rb, and ªpRbº indicates hypophosphor- which binds to Rb and prevents formation of the Rb±E2F
ylated protein.
complex, was coexpressed. However, in cells express-(C) Stable expression of E2F-DB in U2OS cells. Western blots of
ing E2F-DB, the E2F sites were not silencers. We con-several subclones of cells expressing E2F-DB are shown.
(D) Coexpression of p16INK4a±GFP and E2F-DB in U2OS cells. Expres- clude from these results that the high level of E2F-DB
sion of E2F-DB and p16INK4a±GFP is shown by Western blot. stably expressed in the cells is blocking interaction of
(E) p16INK4a±GFP causes accumulation of hypophosphorylated Rb in the Rb±E2F repressor complex with the E2F sites,
U2OS cells stably expressing E2F-DB. A Western blot of Rb in cells thereby preventing the E2F sites from acting as si-
stably expressing E2F-DB and p16INK4a±GFP is shown. As a control,
lencers.wild-type U2OS cells transiently transfected with the p16INK4a expres-
sion vector (and GFP on a separate plasmid) were sorted by flow
cytometry for GFP, and the GFP(1) and GFP(2) cells were also
Stable Expression of E2F-DB Does Not Prolong G1Western blotted for Rb. ªUTº indicates untransfected U2OS cells.
Even though cells stably overexpressing E2F-DB were(F) E2F-DB displaces the Rb±E2F repressor complex from E2F sites
in U2OS cells transfected with the p16INK4a expression vector. Wild- proliferating, we wondered whether E2F-DB might be
type and E2F-DB-expressing U2OS cells were transfected with an delaying entry into S phase. A flow cytometry cell cycle
expression vector for p16INK4a and the reporter construct pE2F-ATF- profile of wild-type and E2F-DB-expressing Mv1Lu cells
CAT, which contains E2F sites upstream of the ATF enhancer (Wein- showed that E2F-DB does not increase the percentage
traub et al., 1992).
of cells in G1 (Table 1). Similar results were seen with(G) E2F-DB prevents downregulation of thymidine kinase (TK),
U2OS cells stably expressing E2F-DB (results not shown).B-myb, and dihydrofolate reductase (DHFR) mRNA when p16INK4a±
GFP is expressed in U2OS cells. We have described the RT±PCR It has been demonstrated previously that overexpres-
analysis for these RNAs in detail previously (Luo et al., 1998). ªp16º sion of E2F-1 can drive cells arrested in G0 by serum
indicates wild-type cells transiently expressing p16INK4a±GFP, ob- starvation into S phase, and that the transactivation
tained by cell sorting for GFP. ªDBº and ªDB1p16º indicate cells domain of E2F-1 is required for this activity (Johnson et
expressing E2F-DB (9-2c, [D]) and E2F-DB 1 p16INK4a±GFP (9-2c10a,
al., 1993; Qin et al., 1994; Shan and Lee, 1994; DeGregori,[E and F]), respectively.
et al., 1995; Krek et al., 1995; Adams and Kaelin, 1996;
Lukas et al., 1996). Indeed, we found that cells express-
ing E2F-DB (which lacks the transactivation domain)and there was little evidence of complexes with either
free wild-type E2F or with wild-type E2F complexed to were still arrested in G0/G1 by serum starvation (Table
1). In fact the cells consistently arrested more rapidlyRb family proteins (Figure 1C and results not shown).
These results suggest that in the nucleus (where the and completely than wild-type cells when serum growth
factors were deprived.ratio of E2F-DB to E2F sites is even greater than that in
Cell
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Table 1. TGFb Arrests Cells at Two Different Stages in the Cell Cycle
Untreated 2 Serum 24 hr 1 T 48 hr 1 T 72 hr 1 T
UT E132 DB UT DB UT DB UT E132 DB UT E132 DB
G1 47.2 51.0 47.9 68.8 81.2 72.6 71.5 79.7 86.2 60.0 87.1 86.2 53.1
S 31.8 27.6 28.0 19.9 10.6 15.3 15.6 7.7 4.5 13.9 4.5 3.7 13.8
G2/M 21.4 21.4 23.8 11.4 7.7 12.0 12.2 12.5 9.0 25.8 8.2 9.8 32.7
Untransfected Mv1Lu cells (UT), cells expressing E2F-DB (DB), or cells expressing E2F-DB with a mutation in the DNA-binding domain (E132)
were subjected to serum starvation for 24 hr, or TGFb treatment (1T) (50 pM) for the indicated time. Cells were then harvested, and the cell
cycle profile was analyzed by flow cytometry. Results are representative of at least three independent experiments, each in duplicate.
E2F-DB Overcomes Growth Suppression by p16INK4a growth of U2OS cells in the same fashion as wild-type
p16INK4a (results not shown). Cells from transfectionWe wondered whether expression of E2F-DB would be
assays were sorted for GFP expression and analyzed forsufficient to prevent G1 arrest by Rb. Rb's growth inhibi-
the level of hypophosphorylated (active) Rb by Westerntory activity is thought to be related to its ability to
blot. Cells expressing p16INK4a±GFP or wild-type p16INK4ainteract with a number of cellular proteins in addition
showed similar accumulation of hypophosphorylatedto E2F, but the relative significance of most of these
Rb (Figure 2B). In contrast, the untransfected cells ininteractions is still unclear. Initially, we transfected an
these assays had no hypophosphorylated Rb.Rb expression vector into cells stably expressing E2F-
Next, we transfected an expression vector for p16INK4a±DB, and we found Rb indeed caused growth arrest in
GFP into clones of U2OS cells stably expressing E2F-colony formation assays (results not shown). These re-
DB (Figures 2C and 2D). As with wild-type p16INK4a,sults suggest that Rb has targets in addition to E2F in
p16INK4a±GFP did not arrest the cells expressing E2F-DB,the cells when it is overexpressed. However, we were
and we isolated a number of green fluorescent clones.concerned that overexpression of Rb might lead to non-
Every clone that we tested expressed p16INK4a±GFP (Fig-physiologic interactions between Rb and cellular pro-
ure 2D). We wondered whether p16INK4a±GFP expressionteins, and thus it was important to maintain a wild-type
had actually triggered accumulation of hypophosphory-level of Rb in order to examine physiologically significant
lated Rb in the E2F-DB-expressing clones. We foundinteractions.
that stable expression of p16INK4a±GFP in E2F-DB cellsOne way to specifically trigger accumulation of hypo-
triggered accumulation of at least as much hypophos-phosphorylated Rb and thus G1 arrest without overex-
phorylated Rb as wild-type cells transiently overex-pression of Rb is expression of p16INK4a (Serrano et al.,
pressing p16INK4a (Figure 2E), but these cells continued1993). p16INK4a binds specifically to CDK4 and 6, blocking
to proliferate.their activity and thereby leading to accumulation of
The Rb±E2F complex can bind to E2F sites and re-hypophosphorylated Rb and growth arrest in G1 (Koh
press transcription by inhibiting activity of surroundinget al., 1995; Lukas et al., 1995). It is functionally linked
enhancers on the promoter. Expression of p16INK4a into Rb and does not suppress growth in Rb(2) cells
U2OS cells leads to accumulation of hypophosphory-
(Palmero and Peters, 1996), suggesting that the only
lated Rb, promoting formation of the Rb±E2F and asso-
target of p16INK4a is the Rb pathway. We reasoned that
ciation of this complex with the promoter. We trans-
if active repression of cell cycle genes by Rb±E2F is a fected a reporter plasmid containing E2F sites and an
primary mechanism through which Rb normally sup- enhancer (as in Figure 1D) into U2OS cells. The U2OS
presses cell proliferation, then E2F-DB should displace cells are p16INK4a(2) and contain only hyperphosphory-
this repressor complex from promoters of cell cycle lated Rb, so an Rb±E2F complex does not form and E2F
genes and overcome the growth suppression by Rb sites do not act as silencers (Figure 2F). However, when
(triggered by p16INK4a). p16INK4a was coexpressed in the transfection assays, hy-
It has been demonstrated previously that expression pophosphorylated Rb accumulated, and the E2F sites
of p16INK4a causes growth arrest of the p16INK4a(2) cell line acted as silencers. In contrast, coexpression of p16INK4a
U2OS (Koh et al., 1995; Lukas et al., 1995). Expression did not cause E2F sites to act as silencers in cells stably
vectors for p16INK4a, the green fluorescent protein (GFP), expressing E2F-DB. Additionally, we found that E2F-
and puromycin resistance were all cotransfected into DB prevented the downregulation of endogenous genes
wild-type U2OS cells and into cells stably expressing containing E2F sites when p16INK4a±GFP was expressed
E2F-DB (Figure 2A; see Western blot for E2F-DB in Fig- in U2OS cells (Figure 2G). We conclude that E2F-DB is
ure 2C). We reasoned that cells expressing both GFP displacing the Rb±E2F complex from promoters.
and the puromycin resistance gene would be more likely Our results demonstrate that (following p16INK4a ex-
to coexpress p16INK4a. As expected, p16INK4a blocked for- pression) accumulation of hypophosphorylated Rb ar-
mation of puromycin-resistant/GFP(1) colonies in the rests cells in G1 by inducing formation of the Rb±E2F
wild-type cells, but it had little effect on such colony repressor complex at the promoter of cell cycle genes,
formation in cells expressing E2F-DB. and not by blocking transcriptional activation by E2F.
To assist in the isolation of colonies expressing Additionally, the results indicate that (with endogenous
p16INK4a, a fusion protein between p16INK4a and GFP was levels of Rb) Rb must interact with E2F to arrest cells
created. GFP was fused to the C-terminal region of in G1 (as opposed to when Rb is overexpressed). Other-
p16INK4a to ensure that cells expressing GFP would also wise, E2F-DB would not be able to relieve the p16INK4a-
induced growth arrest.express p16INK4a. We found that p16INK4a±GFP suppressed
Active Transcriptional Repression by Rb±E2F
57
Figure 3. Expression of E2F-DB Prevents the G1 Arrest and the
Downregulation of Cyclin A and cdc2 in Mv1Lu Epithelial Cells
Treated with TGFb
(A) Wild-type Mv1Lu cells and cells expressing E2F-DB were treated
for 48 hr with 50 pM TGFb1, and percent BrdU(1) nuclei is presented
Figure 4. Blocking Interaction of Rb±E2F with the Promoter and
with standard deviations.
Restoring CDK2 Activity Allow TGFb-Treated Mv1Lu Cells to Prolif-
(B) E2F-DB prevents TGFb from inhibiting expression of cyclin A
erate
and cdc2. Untransfected (UT) Mv1Lu cells and cells expressing E2F-
(A) Rb Western blots of wild-type Mv1Lu cells and cells expressingDB were treated for the indicated times with TGFb, and extracts
E2F-DB. Cells were treated for 48 hr with TGFb as in Figure 3A.were Western blotted. As controls, TGFb and E2F-DB do not affect
(B) TGFb inhibits CDK2 activity in wild-type Mv1Lu cells and in cellsexpression of cyclin E (Koff et al., 1993) or CDK2 (see Figure 4B) in
expressing E2F-DB. An immunoprecipitation-kinase assay for CDK2Mv1Lu cells.
is shown. Histone H1 was used as a substrate for CDK2. A Western
blot for CDK2 is shown below.
(C) Colony formation assays were used to analyze the effect of E2F-E2F-DB Prevents G1 Arrest by TGFb
DB and CDK2 activity on proliferation of Mv1Lu cells treated withTGFb treatment of epithelial cells is another way to trig-
TGFb. Cells were transfected with the indicated expression vectorsger accumulation of hypophosphorylated Rb and arrest
encoding a neo resistance gene, and G418-resistant colonies were
of cells in G1 without overexpression of Rb. We asked selected for 2 weeks. Empty vector controls were included in trans-
whether blocking interaction of the Rb±E2F repressor fections when expression vectors were absent. ªDBº is E2F-DB,
complex with E2F sites by expression of the E2F-DB and ªE/K2º is cyclin E plus CDK2.
would overcome the G1 arrest imposed by TGFb. Un-
transfected mink lung epithelial cells (Mv1Lu) (classically
used for TGFb studies [Massague, 1996]) and cells sta- cycle genes and not through blocking transactivation
by E2F. Also, as with p16INK4a, the endogenous hypo-bly expressing E2F-DB were treated with TGFb, and
incorporation of BrdU was analyzed as an indication of phosphorylated Rb that accumulates in response to
TGFb treatment does not appear to arrest cells in G1DNA synthesis and entry into S phase. As expected,
TGFb inhibited incorporation of BrdU into wild-type by directly targeting proteins other than E2F.
cells; however, it had no effect on BrdU incorporation in
the cells stably expressing E2F-DB (Figure 3A). Western TGFb Arrests Cells at Two Different Stages
in the Cell Cycleblot analysis indicated that E2F-DB blocked the TGFb-
mediated downregulation of cyclin A and cdc2, which It is thought that CDK4/6 and CDK2 progressively phos-
phorylate Rb during G1 (Lundberg and Weinberg, 1997).both contain E2F sites in their promoters (Figure 3B).
Together, the results suggest that preventing interaction CDK4/6 is activated through interaction with D type
cyclins initially in G1; then near the end of G1, cyclin Eof Rb±E2F with cell cycle genes is sufficient to overcome
the G1 block imposed by TGFb. As with wild-type Mv1Lu is expressed, and it forms an active complex with CDK2.
The activity of both CDK4/6 and CDK2 is required forcells, TGFb treatment triggered accumulation of hypo-
phosphorylated Rb in cells stably expressing E2F-DB progression of cells from G1 to S phase, and CDK4/6 and
CDK2 activity is inhibited in TGFb-treated cells (Ewen(Figure 4A). We also immunoprecipitated CDK4 and
CDK2 and analyzed their activity in in vitro kinase et al., 1993; Reynisdottir et al., 1995). In addition to
hyperphosphorylation of Rb, CDK2 seems to have otherassays. Treatment with TGFb resulted in inhibition of
both CDK4 and CDK2 activity in wild-type cells and cells targets that are important regulators of the G1/S transi-
tion. Additionally, CDK2 has been shown to be neces-stably expressing E2F-DB (Ewen et al., 1993; Figure 4B
and results not shown). Thus, expression of E2F-DB sary for assembly of origins of DNA replication and thus
for progression through S phase (Hua and Newport, 1998).does not prevent TGFb from inhibiting CDK activity and
causing accumulation of hypophosphorylated Rb. In- Therefore, we were surprised that E2F-DB-expressing
cells treated with TGFb were able to incorporate BrdUstead, it appears that E2F-DB is functioning by displac-
ing Rb±E2F from the promoter of cell cycle genes. because CDK2 activity was inhibited (Reynisdottir et al.,
1995; Figures 3A and 4B).As with growth suppression by p16INK4a, TGFb appears
to arrest cells in G1 by promoting interaction of the We examined the cell cycle profile of wild-type and
E2F-DB-expressing cells treated with TGFb. Wild-typeRb±E2F repressor complex with the promoter of cell
Cell
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cells were arrested in G1 after 24 hr of treatment with
TGFb, and at longer incubation times the G1 arrest be-
came even more pronounced (Table 1). As with wild-
type cells, treatment of the E2F-DB-expressing cells
with TGFb for 24 hr resulted in an initial arrest in G1
(Table 1). However, when we examined the E2F-DB-
expressing cells after incubation with TGFb for 48 hr
(this 48 hr time point was used for the BrdU studies in
Figure 3A above), we found that they were moving from
G1 to G2/M, and this exit from G1 continued after 72 hr
of treatment with TGFb. The cells remained arrested in
G2/M, which is consistent with the findings that CDK2
activity is required for activation of cdc2 and onset of
mitosis in Xenopus (Guadagno and Newport, 1996), and
that cyclin E-CDK2 is required for reproduction of
centrosomes (Hinchcliffe et al., 1999). As a control in
the above experiments, cells expressing E2F-DB(E132)
arrested like wild-type cells when treated with TGFb
(Table 1). We conclude that DNA binding of E2F-DB,
and therefore the displacement of the Rb±E2F repressor
complex from promoters, is required for S phase entry
when cells are treated with TGFb. Furthermore, it is likely
that there is enough residual CDK2 activity in the TGFb-
treated cells for assembling origins of replication and Figure 5. E2F-DB Overcomes Contact Inhibition in Mv1Lu Epithelial
Cellsmoving through S phase, although movement from G1
(A and B) Mv1Lu cells become contact inhibited as they reach con-to S phase is significantly delayed. However, apparently
fluence, causing them to remain as a monolayer (A). In contrast,this low level of CDK2 activity is not sufficient for the
expression of E2F-DB decreased contact inhibition. The cells con-cells to move through G2/M.
tinue to proliferate after reaching confluence, causing them to pile
Next, we examined proliferation of TGFb-treated cells on top of each other. The photographs are of cells 3 days after
using colony formation assay. Overexpression of cyclin reaching confluence (wild-type cells were plated at a higher density
E or CDK2 alone or in combination did not lead to prolif- and reached confluence before cells expressing E2F-DB).
eration of TGFb-treated cells; however, when E2F-DB
was coexpressed with cyclin E/CDK2, the cells did in-
deed proliferate in the presence of TGFb (Figure 4C). epithelial cells. Thus, we conclude thatÐas with p16INK4a
These results imply that TGFb arrests cells at two dis- and TGFbÐcontact inhibition in epithelial cells is also
tinct stages of the cell cycle. The arrest in G1 is due mediated through transcriptional repression by Rb±E2F,
primarily to induction of the Rb±E2F repressor, whereas and E2F-DB functions by displacing this repressor com-
arrest in G2/M may be a result of decreased CDK2 ac- plex from promoters.
tivity.
Discussion
Contact Inhibition in Epithelial Cells Is Dependent
upon Active Repression by Rb±E2F Rb-Mediated Inhibition of E2F Transactivation
versus Active Repression by Rb±E2FEpithelial cells arrest in G1 in response to cell±cell con-
tact, and as with overexpression of p16INK4a or treatment We and others have found that the Rb±E2F complex can
function as an active transcriptional repressor (Hamel etwith TGFb, this cell±cell contact triggers accumulation
of hypophosphorylated Rb in Mv1Lu cells (Polyak et al., 1992; Weintraub et al., 1992, 1995; Adnane et al.,
1995; Bremner et al., 1995; Sellers et al., 1995; Luo etal., 1994). We wondered whether E2F-DB would also
prevent the G1 arrest imposed by contact inhibition. al., 1998). Nevertheless, the relative contribution of this
repressor activity to cell cycle regulation remained un-Therefore, we cultured wild-type Mv1Lu cells and cells
expressing E2F-DB at confluence for 3 days. The wild- clear. Indeed, it is still thought that transcriptional activa-
tion by E2F is essential for progression from G1 to Stype cells were plated at higher density and actually
reached confluence before the E2F-DB-expressing phase, and that a major function of Rb is to block this
transcriptional activation. Moreover, Rb can interactcells. However, while the wild-type cells arrested in re-
sponse to contact inhibition and maintained a mono- with a number of other cellular proteins in addition to
E2F, and it is thought that at least some of these otherlayer on the culture dishes, cells expressing E2F-DB
continued to proliferate, causing them to pile on top of interactions must be important for Rb's role in regulating
the G1/S transition. Thus, not only is the functional rela-each other (Figures 5A and 5B). Both cells showed simi-
lar accumulation of hypophosphorylated Rb after cul- tionship between Rb and E2F unresolved, the overall
significance of the Rb±E2F interaction (in the face ofture at confluence (results not shown), indicating that
the pathway leading to accumulation of hypophosphor- multiple Rb-binding proteins) is still undetermined.
Our results suggest that Rb must normally (in theylated Rb in response to cell±cell contact is intact in
cells expressing E2F-DB. These results suggest that absence of Rb overexpression) interact with E2F to ar-
rest cells in G1, and it appears that Rb arrests cells inE2F-DB significantly decreases contact inhibition in the
Active Transcriptional Repression by Rb±E2F
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G1 by forming a repressor complex with E2F, not by can interact with histone deacetylase, while bound to a
promoter through E2F, to remodel chromatin and re-blocking the transcriptional activity of E2F. We provide
evidence that p16INK4a, TGFb, and contact inhibition ar- press transcription (Brehm et al., 1998; Luo et al., 1998;
Magnaghi-Jaulin et al., 1998). The binding site for E2Frest cells in G1 through this active transcriptional repres-
sion by Rb±E2F. on Rb is distinct from the site(s) that Rb uses to bind
these other cellular proteins, allowing Rb to interactIt appears that the transactivation domain of E2F-1 is
important in triggering p53-mediated growth arrest or simultaneously with E2F and these other cellular pro-
teins at the promoter. However, both repressor mecha-apoptosis when Rb function is lost and free E2F-1 accu-
mulates (Bates et al., 1998). E2F-1 activates expression nisms are based on the idea that Rb is first recruited to
promoters through interaction with E2F. It is only afterof the alternate reading frame gene (ARF) at the INK4a
locus, whose product inhibits the MDM2-mediated turn- Rb is selectively targeted to and concentrated at pro-
moters via E2F that interaction with these other proteinsover of p53 (Pomerantz et al., 1998; Zhang et al., 1998).
This leads to accumulation of p53 and growth arrest or occurs. Obviously, overexpression of Rb in transfection
assays may facilitate direct interactions with these non-apoptosis. Thus, transactivation by E2F-1 may function
as an additional checkpoint that triggers growth arrest E2F proteins, resulting in a loss of specificity and elimi-
nating the need for Rb to be concentrated initially ator apoptosis when Rb function is lost.
Previously, it was shown that E2F-DB decreased the promoters through E2F before interacting with the non-
E2F proteins.number of cells in S phase and inhibited transcription
of some genes containing E2F sites in Rb(2)/p53(2) Interestingly, Qin et al. found that expression of a
fusion protein between E2F-DB and the VP16 activationcells, resulting in a slower growth rate (Fan and Bertino,
1997). E2F-1 is not required for cell cycle progression domain could overcome growth suppression, even
when Rb is overexpressed (1995). As outlined above,of normal cells in E2F-1(2/2) mice, but tumor cells in
these mice were inhibited from entering S phase (Pan we propose that non-E2F transcription factors directly
targeted by Rb when the protein is overexpressed areet al., 1998). These results suggest that E2F-1 transcrip-
tional activity may be required for the high rate of cell factors that bind to the promoters of cell cycle genes
and are normally (in the absence of overexpression ofcycle progression seen in certain tumors, but not in more
normal cells. Additionally, it has been demonstrated that Rb) only inhibited after Rb is concentrated at the pro-
moter through interaction with E2F. E2F-DB alone can-expression of E2F-DB in functional Rb(2)/p53(2) cells
can lead to a p53-independent form of apoptosis (Hsieh not affect these types of direct interactions between Rb
and non-E2F interactions. However, we demonstratedet al., 1997; Phillips et al., 1997); however, this does not
occur in Rb(1)/p53(1) cells (Qin et al., 1994; Shan and previously that transcriptional activation by VP16 is re-
sistant to repression by Rb (Weintraub et al., 1995), andLee, 1994; Wu and Levine, 1994, and results not shown).
Such apoptosis itself could lead to an apparent de- we suggest that binding of E2F-DB-VP16 to E2F sites
of such cell cycle genes can overcome repression, evencrease in the growth rate of Rb(2)/p53(2) cells in the
presence of E2F-DB. if Rb is directly targeted to the promoter through a non-
E2F protein. Taken together, our studies and the studies
of Qin et al. (1995) suggest that even when overex-Is E2F the Only Functional Target of Rb?
pressed Rb may function in cell cycle regulation by re-E2F-DB is not able to prevent G1 arrest when Rb is
pressing genes with E2F sites. Indeed, we suggest thatoverexpressed in transfection assays. However, in con-
overexpression of Rb leads to short circuiting (bindingtrast to E2F-DB, coexpression of wild-type E2F-1 did
of Rb directly to non-E2F transcription factors that nor-overcome the G1 arrest resulting from overexpression
mally require Rb to first be concentrated at the promoterof Rb (Qin et al., 1995; Sellers et al., 1995). Why would
through interaction with E2F) of a pathway already inE2F-DB overcome G1 arrest by p16INK4a, TGFb, and con-
place to repress genes with E2F sites.tact inhibition in cells with a wild-type level of Rb, yet
be unable to overcome the G1 arrest when Rb is overex-
Experimental Procedurespressed in transfection assays? It appears that with an
endogenous level of Rb, G1 arrest is mediated through
Cell Culture and Transfections
Rb±E2F, and overexpression of either E2F-DB or wild- Mv1Lu epithelial cells, U2OS cells, C2C12 cells, and C33A cells were
type E2F-1 would squelch binding of this repressor com- cultured as described previously (Weintraub et al., 1995). Cells were
plex to promoters. However, when Rb is overexpressed transfected using the calcium phosphate method, and CAT activity
was determined as described (Weintraub et al., 1995). To generatein transfection assays, the high concentration of the
stable clones that overexpress E2F-DB, cells were transfected withprotein leads to nonphysiologic interactions between
CMVneoE2F1(1±374) (Lukas et al., 1996), selected with G418 (1 mg/Rb and non-E2F proteins. Because wild-type E2F-1 con-
ml for Mv1Lu cells, 500 mg/ml for U2OS cells, and 800 mg/ml for
tains an Rb-binding domain (which E2F-DB lacks), it may C2C12 myoblasts) for 2 weeks. Western blot with the mAb KH20
be able to directly titrate Rb in addition to squelching the (Lukas et al., 1996) was used to identify clones expressing E2F-
binding of the Rb±E2F to promoters. DB. To generate U2OS clones that overexpress p16INK4a±GFP, U2OS
clones that express E2F-DB (clones 9-2c and 9-2e) were transfectedOur results do not rule out a function for Rb binding
with pEGFPp16INK4a and puroBabe vector at a ratio of 10:1, and cellsto non-E2F proteins. In contrast, this is the mechanism
were selected with 1 mg/ml of puromycin for 2 weeks. Colonies withthat makes Rb an active transcription repressor; it can
green fluorescence were cloned out and expanded.
bind to and inactivate surrounding transcription factors
while it is concentrated at the promoter of cell cycle Plasmids
genes through interaction with E2F (Weintraub et al., CMV E2F1 and CMV E2F1(1±374) were gifts from K. Helin (Lukas et
al., 1996), Rc-CMV cyclin E was a gift from R. Weinberg (Hinds et1995). Additionally, we and others have found that Rb
Cell
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al., 1992), CMV-CDK2 was a gift from E. Harlow (van den Heuvel pRb and its reversal by specific cyclins. Mol. Cell. Biol. 15, 3256±
3265.et al., 1993), CMV-DP-1 was a gift from D. Livingston (Krek et al.,
1993), CMV-E2F3 was a gift from J. Lees (Lees et al., 1993), CMV- Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M., and Nevins,
E2F5 was a gift from R. Bernards (Hijmans et al., 1995), and p16INK4a J.R. (1991). The E2F transcription factor is a cellular target for the
expression vectors were gifts from Y. Xiong (Guan et al., 1994). RB protein. Cell 65, 1053±1061.
p16INK4a cDNA was amplified by PCR and cloned into the HindIII and Cress, W.D., Johnson, D.G., and Nevins, J.R. (1993). A genetic analy-
BamHI sites of pEGFPN1 (Clontech). E2F-CAT, E2F-ATF-CAT, and sis of the E2F1 gene distinguishes regulation by Rb, p107, and
mut-E2F-ATF-CAT were described previously (Weintraub et al., adenovirus E4. Mol. Cell. Biol. 13, 6314±6325.
1992).
DeGregori, J., Leone, G., Ohtani, K., Miron, A., and Nevins, J.R.
(1995). E2F-1 accumulation bypasses a G1 arrest resulting from the
BrdU Labeling inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9,
Mv1Lu cells were plated onto coverslips 1 day before adding TGFb1 2873±2887.
(50 pM). After 48 hr of TGFb1 treatment, cells were labeled with
Ewen, M.E. (1994). The cell cycle and the retinoblastoma proteinBrdU (Amersham) (1:500 dilution) for 3 hr. Cells on coverslips were
family. Cancer Metastasis Rev. 13, 45±66.washed twice with PBS, fixed with 70% ethanol at 2208C, rinsed
Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M.with PBS, denatured with 2N HCL/0.5% NP40 for 45 min at room
(1993). TGF-beta inhibition of Cdk4 synthesis is linked to cell cycletemperature, then neutralized with 0.1 M sodium borate at pH 8.5.
arrest. Cell 74, 1009±1020.Cells were blocked with 2% BSA/0.1% Tween 20 in PBS for 1 hr at
room temperature, then incubated with fluorescein-conjugated anti- Ewen, M.E., Oliver, C.J., Sluss, H.K., Miller, S.J., and Peeper, D.S.
BrdU antibody (Caltag, 1:100 dilution) for 30 min. After three washes, (1995). p53-dependent repression of cdk4 translation in TGF-beta
cells were incubated with DAPI (Boehringer Mannheim) for 1 hr. induced cell-cycle arrest. Genes Dev. 9, 204±217.
Coverslips were washed with PBS and mounted. Fan, J., and Bertino, J.R. (1997). Functional roles of E2F in cell cycle
regulation. Oncogene 14, 1191±1200.
Cell Cycle Analysis Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.J., Livingston,
For flow cytometry, cells were harvested and fixed in 70% ethanol D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in
and then treated with 50 mg/ml of propidium iodide and 100 U/ml mice to promote apoptosis and suppress proliferation. Cell 85,
of RNase A. At least 10,000 cells were scored using a FACScan 549±561.
flow cytometer. Cell cycle distribution was analyzed with CellQuest
Guadagno, T.M., and Newport, J.W. (1996). Cdk2 kinase is required
software.
for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase
activity. Cell 84, 73±82.
Gel Shifts
Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X.Y., Okeefe,Gel shift assays were performed as described (Helin et al., 1993)
C.L., Matera, A.G., and Xiong, Y. (1994). Growth suppression bywith nuclear extract from wild-type Mv1Lu cells or cells expressing
p18, a p16(ink4/mts1)- and p14(ink4b/mts2)-related cdk6 inhibitor,E2F-DB. The E2F site from the dihydrofolate reductase gene pro-
correlates with wild-type pRb function. Genes Dev. 8, 2939±2952.
moter was used as a probe: 59-ATTTAAGTTTCGCGCCCTTTCT
Hamel, P.A., Gill, R.M., Phillips, R.A., and, Gallie, B.L. (1992). Tran-CAA-39. The mutant probe sequence was 59-ATTTAAGTTTCGATCC
scriptional repression of the E2-containing promoters EIIaE, c-myc,CTTTCTCAA-39.
and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12, 3431±
3438.Kinase Assays
Helin, K., Wu, C.L., Fattaey, A.R., Lees, J.A., Dynlacht, B.D., Ngwu,Immunoprecipitation-kinase assays were performed as described
C., and Harlow, E. (1993). Heterodimerization of the transcription(Ewen et al., 1993). For CDK2 kinase assays, a Sepharose-conju-
factors E2F-1 and DP-1 leads to cooperative trans-activation. Genesgated anti-CDK2 antibody (Santa Cruz) was incubated with 200 mg
Dev. 7, 1850±1861.of Mv1Lu cell lysate, and immunocomplexes were washed with lysis
Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., Vantveer, L.J.,buffer followed by kinase buffer. Five micrograms of histone H1
and Bernards, R. (1995). E2f-5, a new e2f family member that inter-(Boehringer Mannheim), 10 mCi of g-ATP[32P], and 10 mM ATP were
acts with p130 in vivo. Mol. Cell. Biol. 15, 3082±3089.added to the immunocomplex in a final volume of 50 ml, and the
mixture was incubated for 30 min at 308C. Hinchcliffe, E.H., Li, C., Thompson, E.A., Maller, J.L., and Sluder, G.
(1999). Requirement of cdk2-cyclin E activity for repeated centro-
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